Naproxcinod

Naproxcinod is a prescription medication used to treat the pain and inflammation associated with osteoarthritis. It is a non-steroidal anti-inflammatory drug (NSAID) and works by inhibiting the activity of an enzyme in the body that produces substances that cause inflammation. It is available in tablet form and is to be taken orally. Common side effects include nausea, stomach pain, diarrhea, constipation, and headache.

Naproxcinod is a medication that falls under the category of nonsteroidal anti-inflammatory drugs (NSAIDs). It was designed to be an improvement over traditional NSAIDs like naproxen. Here's a breakdown of key points about Naproxcinod:

• Function: It has a dual mechanism of action. It works similarly to naproxen to reduce inflammation and pain, but it also releases nitric oxide (NO) which may offer additional benefits [1, 2].
• Benefits (intended): Compared to regular NSAIDs, Naproxcinod was hoped to provide pain relief with potentially less gastrointestinal (stomach) irritation and cardiovascular (heart) side effects [1, 2].
• Development Status: Naproxcinod was under development as part of a new class of drugs called cyclooxygenase-inhibiting nitric oxide donators (CINODs) [1]. However, it did not receive approval from the FDA (Food and Drug Administration) in the US in 2010 [6].

Current Use: There is no current information available on its use in mainstream medicine.